These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35857139)

  • 1. Motor-neuron-disease-like phenotype associated with IgLON5 disease.
    Sista SR; Crum B; Aboseif A; Devine MF; Zekeridou A; Hammami MB; Rezk MM; Truffert A; Lalive PH; Kunchok A; McKeon A; Dubey D
    J Neurol; 2022 Nov; 269(11):6139-6144. PubMed ID: 35857139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IgLON5 Disease: A New Bulbar-Onset Motor Neuron Mimic Syndrome.
    Werner J; Jelcic I; Schwarz EI; Probst-Müller E; Nilsson J; Schwizer B; Bloch KE; Lutterotti A; Jung HH; Schreiner B
    Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33531378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of IgLON5-IgG and SOX1-IgG in a Patient with Progressive Brainstem Dysfunction.
    Teekaput C; Teekaput K; Tanprawate S; Kittisares A; Apiwattanakul M
    Acta Neurol Taiwan; 2023 Sep; 32(3)():131-135. PubMed ID: 37674426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IgLON5 Disease Showing an Improvement in Dysautonomia, Including Vocal Cord Palsy, via Combined Immunotherapy.
    Sato D; Sato H; Kondo T; Igari R; Iseki C; Kawahara H; Amano S; Ono Y; Kimura A; Shimohata T; Ohta Y
    Intern Med; 2024 Aug; 63(15):2187-2191. PubMed ID: 38171876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IgLON5 disease as a differential diagnosis of multiple system atrophy.
    Ono Y; Tadokoro K; Yunoki T; Yamashita T; Sato D; Sato H; Akamatsu S; Mizukami H; Ohta Y; Yamano Y; Kimura A; Shimohata T
    Parkinsonism Relat Disord; 2024 Jul; 124():106992. PubMed ID: 38701719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New knowledge on anti-IgLON5 disease.
    Gaig C; Sabater L
    Curr Opin Neurol; 2024 Jun; 37(3):316-321. PubMed ID: 38563128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgLON5 autoimmunity tested positive in patients with isolated chronic insomnia disease.
    Aghelan Z; Karima S; Ghadami MR; Khazaie H; Bahrehmand F; Vaisi-Raygani A; Abtahi SH; Khodarahmi R
    Clin Exp Immunol; 2022 Apr; 207(2):237-240. PubMed ID: 35020856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease.
    Cluse F; Hermier M; Demarquay G; Rogemond V; Mallaret M; Svahn J; Pegat A; Honnorat J; Bernard E
    Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37607754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.
    Sabater L; Gaig C; Gelpi E; Bataller L; Lewerenz J; Torres-Vega E; Contreras A; Giometto B; Compta Y; Embid C; Vilaseca I; Iranzo A; Santamaría J; Dalmau J; Graus F
    Lancet Neurol; 2014 Jun; 13(6):575-86. PubMed ID: 24703753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and Neurodegeneration.
    Landa J; Gaig C; Plagumà J; Saiz A; Antonell A; Sanchez-Valle R; Dalmau J; Graus F; Sabater L
    Ann Neurol; 2020 Nov; 88(5):1023-1027. PubMed ID: 32740999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome.
    Sabater L; Planagumà J; Dalmau J; Graus F
    J Neuroinflammation; 2016 Sep; 13(1):226. PubMed ID: 27586161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice.
    Ni Y; Feng Y; Shen D; Chen M; Zhu X; Zhou Q; Gao Y; Liu J; Zhang Q; Shen Y; Peng L; Zeng Z; Yin D; Hu J; Chen S
    J Neuroinflammation; 2022 Jun; 19(1):140. PubMed ID: 35690819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia.
    Rowland LP
    Acta Myol; 2011 Jun; 30(1):29-31. PubMed ID: 21842590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum?
    Strong MJ; Gordon PH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):8-16. PubMed ID: 16036421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot Study of the Effects of Chronic Intracerebroventricular Infusion of Human Anti-IgLON5 Disease Antibodies in Mice.
    Alvente S; Matteoli G; Molina-Porcel L; Landa J; Alba M; Bastianini S; Berteotti C; Graus F; Lo Martire V; Sabater L; Zoccoli G; Silvani A
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
    Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
    Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient and rapid conversion of human astrocytes and ALS mouse model spinal cord astrocytes into motor neuron-like cells by defined small molecules.
    Zhao AD; Qin H; Sun ML; Ma K; Fu XB
    Mil Med Res; 2020 Sep; 7(1):42. PubMed ID: 32892745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Motor Abnormalities in Anti-IgLON5 Disease.
    Macher S; Milenkovic I; Zrzavy T; Höftberger R; Seidel S; Berger-Sieczkowski E; Berger T; Rommer PS; Wiest G
    Front Immunol; 2021; 12():753856. PubMed ID: 34659261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease.
    Koneczny I; Macher S; Hutterer M; Seifert-Held T; Berger-Sieczkowski E; Blaabjerg M; Breu M; Dreyhaupt J; Dutra LA; Erdler M; Fae I; Fischer G; Frommlet F; Heidbreder A; Högl B; Klose V; Klotz S; Liendl H; Nissen MS; Rahimi J; Reinecke R; Ricken G; Stefani A; Süße M; Teive HAG; Weis S; Berger T; Sabater L; Gaig C; Lewerenz J; Höftberger R
    Front Immunol; 2024; 15():1376456. PubMed ID: 38827736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.